Childhood IgM nephropathy: comparison with minimal change disease.
The distinctiveness of IgM nephropathy (IgMN) as a clinicopathologic entity is controversial. Twenty-seven children (16 males, 11 females) with IgMN as defined immunohistochemically by diffuse mesangial staining of glomeruli for IgM were compared to a group of 63 children (40 males, 23 females) with minimal change disease (MCD). While mesangial expansion was significantly greater in IgMN than in MCD (p = 0.0014), there were no significant differences between the two groups with respect to the other biopsy factors. IgMN showed a significantly higher incidence of hypertension at presentation. More than 90% of patients in both groups presented with the nephrotic syndrome which in most initially responded to prednisone. Frequently relapsing/steroid-dependent nephrotic syndrome was the most common indication for biopsy in both groups. Approximately 60% of patients from both groups received cytotoxic therapy. Eight percent of IgMN and 7% of MCD patients failed to respond to therapy. Relapse rates and mean dose of prednisone at relapse were very similar in both groups prior to biopsy. Relapse rates diminished significantly after treatment in the postbiopsy interval, but mean dose of prednisone at relapse did not change appreciably over time. None of the patients developed renal failure or hypertension in the follow-up period. At last visit 23% of IgMN and 27% of MCD had proteinuria. The results indicate that IgMN and MCD are indistinguishable clinically in children who are biopsied for the nephrotic syndrome.
Al-Eisa
A
A
Department of Pediatrics, University of British Columbia, Vancouver, Canada.
Carter
J E
JE
Lirenman
D S
DS
Magil
A B
AB
D001706:Biopsy; D002648:Child; D002675:Child, Preschool; D002857:Chromium / Q000097:blood; D005260:Female; D005920:Glomerular Mesangium / Q000378:metabolism* / Q000648:ultrastructure; D006417:Hematuria / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000378:metabolism; D007075:Immunoglobulin M / Q000032:analysis / Q000378:metabolism*; D007150:Immunohistochemistry; D007223:Infant; D007674:Kidney Diseases / Q000188:drug therapy / Q000473:pathology / Q000503:physiopathology*; D008297:Male; D008854:Microscopy, Electron; D009402:Nephrosis, Lipoid / Q000378:metabolism; D011241:Prednisone / Q000494:pharmacology; D011507:Proteinuria / Q000378:metabolism; D012189:Retrospective Studies
D007075:Immunoglobulin M; D002857:Chromium; D011241:Prednisone